CM Hospitalar S/A (BVMF: VVEO3)
2.140
+0.190 (9.74%)
Sep 11, 2024, 5:06 PM GMT-3
CM Hospitalar S/A Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 11,462 | 11,084 | 8,747 | 6,219 | 4,413 | 3,003 | Upgrade
|
Revenue Growth (YoY) | 11.99% | 26.72% | 40.65% | 40.91% | 46.96% | 13.71% | Upgrade
|
Cost of Revenue | 9,818 | 9,349 | 7,350 | 5,121 | 3,775 | 2,534 | Upgrade
|
Gross Profit | 1,644 | 1,735 | 1,397 | 1,097 | 638.47 | 469.45 | Upgrade
|
Selling, General & Admin | 1,248 | 1,141 | 863.53 | 671.86 | 420.34 | 315.02 | Upgrade
|
Other Operating Expenses | -15.16 | -18.87 | 9.59 | -71.19 | 18.64 | 90.55 | Upgrade
|
Operating Expenses | 1,223 | 1,114 | 879.09 | 602.01 | 441.2 | 407.55 | Upgrade
|
Operating Income | 420.58 | 620.88 | 517.58 | 495.3 | 197.27 | 61.9 | Upgrade
|
Interest Expense | -465 | -469.03 | -336.68 | -386.75 | -351.45 | -121.41 | Upgrade
|
Interest & Investment Income | 92.74 | 103.08 | 151.06 | 303.31 | 344.01 | 42.15 | Upgrade
|
Earnings From Equity Investments | -1.66 | -1.68 | -3.53 | -3 | -0.25 | - | Upgrade
|
Currency Exchange Gain (Loss) | -33.7 | 17.39 | 19.97 | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -74.69 | -149.39 | -139.64 | - | - | - | Upgrade
|
EBT Excluding Unusual Items | -61.73 | 121.25 | 208.77 | 408.85 | 189.59 | -17.36 | Upgrade
|
Merger & Restructuring Charges | -28.65 | -4.9 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 6.71 | 7.15 | 6.35 | - | - | - | Upgrade
|
Legal Settlements | -29.37 | -0.21 | -7.04 | - | - | - | Upgrade
|
Other Unusual Items | -10.27 | 15.2 | - | - | - | - | Upgrade
|
Pretax Income | -123.31 | 138.5 | 208.08 | 408.85 | 189.59 | -17.36 | Upgrade
|
Income Tax Expense | -306.19 | -221.42 | -51.65 | 13.7 | 67.82 | -53.1 | Upgrade
|
Earnings From Continuing Operations | 182.88 | 359.92 | 259.73 | 395.16 | 121.77 | 35.75 | Upgrade
|
Net Income | 182.88 | 359.92 | 259.73 | 395.16 | 121.77 | 35.75 | Upgrade
|
Net Income to Common | 182.88 | 359.92 | 259.73 | 395.16 | 121.77 | 35.75 | Upgrade
|
Net Income Growth | -12.67% | 38.57% | -34.27% | 224.52% | 240.63% | 4.86% | Upgrade
|
Shares Outstanding (Basic) | 318 | 300 | 284 | 262 | 225 | 155 | Upgrade
|
Shares Outstanding (Diluted) | 318 | 300 | 284 | 262 | 225 | 155 | Upgrade
|
Shares Change (YoY) | 12.11% | 5.69% | 8.53% | 16.35% | 44.65% | -0.68% | Upgrade
|
EPS (Basic) | 0.58 | 1.20 | 0.92 | 1.51 | 0.54 | 0.23 | Upgrade
|
EPS (Diluted) | 0.58 | 1.20 | 0.92 | 1.51 | 0.54 | 0.23 | Upgrade
|
EPS Growth | -22.14% | 31.04% | -39.41% | 178.91% | 135.49% | 5.57% | Upgrade
|
Free Cash Flow | -416.81 | -1,064 | 380.51 | 242.16 | 136.25 | 142.09 | Upgrade
|
Free Cash Flow Per Share | -1.31 | -3.55 | 1.34 | 0.93 | 0.61 | 0.91 | Upgrade
|
Dividend Per Share | - | - | 0.277 | 0.405 | - | - | Upgrade
|
Dividend Growth | - | - | -31.57% | - | - | - | Upgrade
|
Gross Margin | 14.34% | 15.65% | 15.97% | 17.65% | 14.47% | 15.63% | Upgrade
|
Operating Margin | 3.67% | 5.60% | 5.92% | 7.96% | 4.47% | 2.06% | Upgrade
|
Profit Margin | 1.60% | 3.25% | 2.97% | 6.35% | 2.76% | 1.19% | Upgrade
|
Free Cash Flow Margin | -3.64% | -9.60% | 4.35% | 3.89% | 3.09% | 4.73% | Upgrade
|
EBITDA | 566.7 | 797.63 | 645.35 | 593.49 | 279.54 | 116.92 | Upgrade
|
EBITDA Margin | 4.94% | 7.20% | 7.38% | 9.54% | 6.33% | 3.89% | Upgrade
|
D&A For EBITDA | 146.12 | 176.75 | 127.78 | 98.19 | 82.27 | 55.02 | Upgrade
|
EBIT | 420.58 | 620.88 | 517.58 | 495.3 | 197.27 | 61.9 | Upgrade
|
EBIT Margin | 3.67% | 5.60% | 5.92% | 7.96% | 4.47% | 2.06% | Upgrade
|
Effective Tax Rate | - | - | - | 3.35% | 35.77% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.